Back
Guidewire Software Vs. Kymera Therapeutics Industry Stock Comparison
Buy
53
GWRE
Guidewire Software
Last Price:
$219.93
Seasonality Move:
6.57%
Buy
56
KYMR
Kymera Therapeutics
Last Price:
$44.49
Seasonality Move:
5.78%
Buy
53
Guidewire Software (GWRE)
is a Buy
Is Guidewire Software a Buy, Sell or Hold?
-
The current Guidewire Software [GWRE] share price is $220.15. The Score for GWRE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
GWRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $44.48. The Score for KYMR is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GWRE Stock Price Chart
What is Guidewire Software's stock price today?
-
The Guidewire Software share price today is $220.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GWRE is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $44.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
GWRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 50.14 | Buy |
Relative Strength Index (14 RSI): | 35.62 | Sell |
Chaikin Money Flow: | -425421 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (229.63 - 251.13) | Sell |
Bollinger Bands (100): | (188 - 232.06) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.93 | Buy |
Relative Strength Index (14 RSI): | 55.13 | Buy |
Chaikin Money Flow: | -27977 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.46 - 47.42) | Sell |
Bollinger Bands (100): | (27.32 - 42.48) | Buy |
GWRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 228.74 | Sell |
20-day SMA: | 236.89 | Sell |
50-day SMA: | 227.14 | Sell |
200-day SMA: | 198.99 | Buy |
8-day EMA: | 143.01 | Buy |
20-day EMA: | 74.65 | Buy |
50-day EMA: | 33.5 | Buy |
200-day EMA: | 8.89 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.48 | Sell |
20-day SMA: | 45.45 | Sell |
50-day SMA: | 39.14 | Buy |
200-day SMA: | 39.49 | Buy |
8-day EMA: | 28.31 | Buy |
20-day EMA: | 14.72 | Buy |
50-day EMA: | 6.59 | Buy |
200-day EMA: | 1.75 | Buy |
Guidewire Software Earnings Growth & GWRE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, an increase next quarter of $0.16 per share, an increase this year of $1.12 per share, and an increase next year of $0.39 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.20 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.41 per share.
Guidewire Software Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |